Altre lingue North China Pharmaceutical Company.Ltd

Azioni

600812

CNE000000D16

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 10/07/2024			Variaz. 5gg	Var. 1 gen.
4,14 ^CNY	0,00%		-3,94%	-27,37%

03/06	La Cina concede l'approvazione alla commercializzazione dell'ampicillina sodica come principio attivo farmaceutico	MT
24/05	L'unità di North China Pharmaceutical supera l'ispezione GMP	MT

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

China Grants Marketing Approval for Ampicillin Sodium as Active Pharmaceutical Ingredient	03/06
North China Pharmaceutical's Unit Passes GMP Inspection	24/05
North China Pharmaceutical Unit Gets China Nod for Rabies Vaccine	17/05
North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
North China Pharmaceutical Company.Ltd agreed to acquire the remaining 35.85% stake in NCPC Hebei Huamin Pharmaceutical Co., Ltd. from CCB Financial Asset Investment Co., Ltd. for CNY 670 million	30/03
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
North China Pharmaceutical Subsidiary Gets Europe's Compliance Certification for Drug Raw Material	27/02
Jizhong Energy Group Finance Co., Ltd announced that it has received CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd	06/12
North China Pharmaceutical Gets Nod to Market Ampicillin API	20/11
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
North China Pharmaceutical Company.Ltd(XSSC:600812) added to S&P Global BMI Index	18/09/23
North China Pharmaceutical Company.Ltd(XSSC:600812) added to FTSE All-World Index	18/09/23
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	18/08/23
Jizhong Energy Group Finance Co., Ltd announced that it expects to receive CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd	17/08/23
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23
North China Pharma Unit Passes Compliance Inspection	31/03/23
North China Pharmaceutical's Heart Drug Passes Regulatory Evaluation	13/02/23
North China Pharmaceutical Company Ltd.(SHSE:600812) dropped from Shanghai Stock Exchange Health Care Sector Index	09/12/22
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue North China Pharmaceutical Company.Ltd

Azioni

600812

CNE000000D16

Altre lingue

Filtri